Targeting EMT in cancer: opportunities for pharmacological intervention

Area of Science:

• Oncology
• Cancer Biology
• Molecular Medicine

Background:

• Cancer metastasis to distant organs is a significant clinical challenge.
• Epithelial-mesenchymal transition (EMT) is a key process regulating cancer cell invasion and metastasis.
• EMT is implicated in generating cancer stem cells and conferring resistance to therapies.

Purpose of the Study:

• To review therapeutic strategies targeting the EMT pathway in cancer treatment.
• To summarize evidence for proposed EMT targets.
• To discuss the advantages and disadvantages of EMT-based therapeutic approaches.

Main Methods:

• Literature review of studies on EMT and cancer therapy.
• Analysis of proposed EMT targets and their therapeutic potential.
• Evaluation of clinical challenges and opportunities in targeting EMT.

Main Results:

• EMT plays a critical role in cancer cell invasion, metastasis, and therapeutic resistance.
• Targeting EMT pathways presents a viable strategy for both preventing and treating metastatic cancer.
• Various EMT targets show promise, but each approach has potential benefits and drawbacks.

Conclusions:

• EMT-based therapies hold significant therapeutic interest for managing cancer metastasis.
• Targeting EMT could prevent tumor dissemination in high-risk patients and eradicate existing metastases.
• Careful consideration of advantages and pitfalls is crucial for designing effective EMT-targeted treatments.